LTR Pharma (ASX:LTP) PEG Ratio : N/A (As of Mar. 29, 2025)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, LTR Pharma's PE Ratio without NRI is 0.00. LTR Pharma's 5-Year EBITDA growth rate is 0.00%. Therefore, LTR Pharma's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

The historical rank and industry rank for LTR Pharma's PEG Ratio or its related term are showing as below:

ASX:LTP's PEG Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.42
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

LTR Pharma PEG Ratio Historical Data

The historical data trend for LTR Pharma's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma PEG Ratio Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

PEG Ratio

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23	Dec23	Jun24	Dec24
PEG Ratio	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of LTR Pharma's PEG Ratio

For the Biotechnology subindustry, LTR Pharma's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's PEG Ratio distribution charts can be found below:

* The bar in red indicates where LTR Pharma's PEG Ratio falls into.

Save Embed

;

Save Embed

;

LTR Pharma PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

LTR Pharma's PEG Ratio for today is calculated as

PEG Ratio	=	PE Ratio without NRI	/	5-Year EBITDA Growth Rate*
	=		/	0.00
	=	N/A

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

LTR Pharma (ASX:LTP) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

LTR Pharma PEG Ratio Related Terms

Thank you for viewing the detailed overview of LTR Pharma's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » PEG Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

LTR Pharma Headlines

No Headlines